世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界のアジルサルタン メドキソミル原薬販売市場レポート2022年版


Global Azilsartan Medoxomil API Sales Market Report 2022

市場の分析と洞察。アジルサルタン メドキソミル原薬の世界市場 COVID-19の流行により、アジルサルタン メドキソミルAPIの世界市場規模は2021年に1,505万米ドルと推定され、レビュー期間(2022-2028)にはCAGR 1... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2022年3月1日 US$4,000
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

市場の分析と洞察。アジルサルタン メドキソミル原薬の世界市場
COVID-19の流行により、アジルサルタン メドキソミルAPIの世界市場規模は2021年に1,505万米ドルと推定され、レビュー期間(2022-2028)にはCAGR 19.96% で2028年までに5,568万米ドルの再調整サイズとなると予測されています。
世界のアジルサルタン メドキソミルAPIの範囲と市場規模
アジルサルタン メドキソミル原薬の世界市場は、企業別、地域(国)別、タイプ別、用途別に分類されています。世界のアジルサルタン メドキソミルAPI市場におけるプレイヤー、ステークホルダー、その他の参加者は、このレポートを強力なリソースとして利用することで、優位に立つことができるようになることでしょう。セグメント別分析では、2017年から2028年までの地域(国)別、用途別の売上、収益、予測に焦点を当てます。

会社別
武田薬品工業
ルパン
アキュララボ
メトロケムAPI
ジュビラント・ファーマ
浙江省宏源市
オナーラボ
HECファーム
エノマーク
CTXライフサイエンス
浙江天宇
珠海倫敦
ヴァリアント社

用途別セグメント
20mg錠剤
40mg錠剤
80mg錠剤
地域別
米国
欧州
中国
日本
インド
ラテンアメリカ
その他の地域

ページTOPに戻る


目次


1 Azilsartan Medoxomil API Market Overview 1
1.1 Azilsartan Medoxomil API Product Scope 1
1.2 Azilsartan Medoxomil API Segment by Application 1
1.2.1 Global Azilsartan Medoxomil API Sales Comparison by Application (2017 & 2021 & 2028) 2
1.2.2 20 mg Tablets 3
1.2.3 40 mg Tablets 4
1.2.4 80 mg Tablets 4
1.3 Global Azilsartan Medoxomil API Market Estimates and Forecasts (2017-2028) 5
1.3.1 Global Azilsartan Medoxomil API Market Size in Value Growth Rate (2017-2028) 5
1.3.2 Global Azilsartan Medoxomil API Market Size in Volume Growth Rate (2017-2028) 7
1.3.3 Global Azilsartan Medoxomil API Price Trends (2017-2028) 8
2 Azilsartan Medoxomil API Estimates and Forecasts by Region 9
2.1 Global Azilsartan Medoxomil API Market Size by Region: 2017 VS 2021 VS 2028 9
2.2 Global Azilsartan Medoxomil API Retrospective Market Scenario by Region (2017-2022) 10
2.2.1 Global Azilsartan Medoxomil API Sales Market Share by Region (2017-2022) 10
2.2.2 Global Azilsartan Medoxomil API Revenue Market Share by Region (2017-2022) 11
2.3 Global Azilsartan Medoxomil API Market Estimates and Forecasts by Region (2023-2028) 13
2.3.1 Global Azilsartan Medoxomil API Sales Estimates and Forecasts by Region (2023-2028) 13
2.3.2 Global Azilsartan Medoxomil API Revenue Forecast by Region (2023-2028) 13
2.4 Geographic Market Analysis: Market Facts & Figures 15
2.4.1 United States Azilsartan Medoxomil API Estimates and Projections (2017-2028) 15
2.4.2 Europe Azilsartan Medoxomil API Estimates and Projections (2017-2028) 16
2.4.3 China Azilsartan Medoxomil API Estimates and Projections (2017-2028) 17
2.4.4 Japan Azilsartan Medoxomil API Estimates and Projections (2017-2028) 18
2.4.5 India Azilsartan Medoxomil API Estimates and Projections (2017-2028) 19
2.4.6 Latin America Azilsartan Medoxomil API Estimates and Projections (2017-2028) 20
3 Azilsartan Medoxomil API Competition Landscape by Players 22
3.1 Global Top Azilsartan Medoxomil API Players by Sales (2017-2022) 22
3.2 Global Top Azilsartan Medoxomil API Players by Revenue (2017-2022) 23
3.3 Global Azilsartan Medoxomil API Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Azilsartan Medoxomil API as of 2021) 25
3.4 Global Azilsartan Medoxomil API Average Price by Company (2017-2022) 27
3.5 Manufacturers Azilsartan Medoxomil API Manufacturing Sites, Area Served 28
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans 29
4 Global Azilsartan Medoxomil API Market Size by Application 30
4.1 Global Azilsartan Medoxomil API Historic Market Review by Application (2017-2022) 30
4.1.1 Global Azilsartan Medoxomil API Sales by Application (2017-2022) 30
4.1.2 Global Azilsartan Medoxomil API Revenue by Application (2017-2022) 30
4.1.3 Global Azilsartan Medoxomil API Price by Application (2017-2022) 32
4.2 Global Azilsartan Medoxomil API Market Estimates and Forecasts by Application (2023-2028) 32
4.2.1 Global Azilsartan Medoxomil API Sales Forecast by Application (2023-2028) 32
4.2.2 Global Azilsartan Medoxomil API Revenue Forecast by Application (2023-2028) 33
4.2.3 Global Azilsartan Medoxomil API Price Forecast by Application (2023-2028) 33
5 United States Azilsartan Medoxomil API Market Facts & Figures 34
5.1 United States Azilsartan Medoxomil API Sales by Company 34
5.1.1 United States Azilsartan Medoxomil API Sales by Company (2017-2022) 34
5.1.2 United States Azilsartan Medoxomil API Revenue by Company (2017-2022) 35
5.2 United States Azilsartan Medoxomil API Sales Breakdown by Application 36
5.2.1 United States Azilsartan Medoxomil API Sales Breakdown by Application (2017-2022) 36
5.2.2 United States Azilsartan Medoxomil API Sales Breakdown by Application (2023-2028) 36
6 Europe Azilsartan Medoxomil API Market Facts & Figures 38
6.1 Europe Azilsartan Medoxomil API Sales by Company 38
6.1.1 Europe Azilsartan Medoxomil API Sales by Company (2017-2022) 38
6.1.2 Europe Azilsartan Medoxomil API Revenue by Company (2017-2022) 38
6.2 Europe Azilsartan Medoxomil API Sales Breakdown by Application 39
6.2.1 Europe Azilsartan Medoxomil API Sales Breakdown by Application (2017-2022) 39
6.2.2 Europe Azilsartan Medoxomil API Sales Breakdown by Application (2023-2028) 40
7 China Azilsartan Medoxomil API Market Facts & Figures 41
7.1 China Azilsartan Medoxomil API Sales by Company 41
7.1.1 China Azilsartan Medoxomil API Sales by Company (2017-2022) 41
7.1.2 China Azilsartan Medoxomil API Revenue by Company (2017-2022) 41
7.2 China Azilsartan Medoxomil API Sales Breakdown by Application 42
7.2.1 China Azilsartan Medoxomil API Sales Breakdown by Application (2017-2022) 42
7.2.2 China Azilsartan Medoxomil API Sales Breakdown by Application (2023-2028) 43
8 Japan Azilsartan Medoxomil API Market Facts & Figures 44
8.1 Japan Azilsartan Medoxomil API Sales by Company 44
8.1.1 Japan Azilsartan Medoxomil API Sales by Company (2017-2022) 44
8.1.2 Japan Azilsartan Medoxomil API Revenue by Company (2017-2022) 44
8.2 Japan Azilsartan Medoxomil API Sales Breakdown by Application 45
8.2.1 Japan Azilsartan Medoxomil API Sales Breakdown by Application (2017-2022) 45
8.2.2 Japan Azilsartan Medoxomil API Sales Breakdown by Application (2023-2028) 46
9 India Azilsartan Medoxomil API Market Facts & Figures 47
9.1 India Azilsartan Medoxomil API Sales by Company 47
9.1.1 India Azilsartan Medoxomil API Sales by Company (2017-2022) 47
9.1.2 India Azilsartan Medoxomil API Revenue by Company (2017-2022) 48
9.2 India Azilsartan Medoxomil API Sales Breakdown by Application 49
9.2.1 India Azilsartan Medoxomil API Sales Breakdown by Application (2017-2022) 49
9.2.2 India Azilsartan Medoxomil API Sales Breakdown by Application (2023-2028) 49
10 Latin America Azilsartan Medoxomil API Market Facts & Figures 51
10.1 Latin America Azilsartan Medoxomil API Sales by Company 51
10.1.1 Latin America Azilsartan Medoxomil API Sales by Company (2017-2022) 51
10.1.2 Latin America Azilsartan Medoxomil API Revenue by Company (2017-2022) 52
10.2 Latin America Azilsartan Medoxomil API Sales Breakdown by Application 53
10.2.1 Latin America Azilsartan Medoxomil API Sales Breakdown by Application (2017-2022) 53
10.2.2 Latin America Azilsartan Medoxomil API Sales Breakdown by Application (2023-2028) 53
11 Company Profiles and Key Figures in Azilsartan Medoxomil API Business 55
11.1 Takeda 55
11.1.1 Takeda Corporation Information 55
11.1.2 Takeda Business Overview 55
11.1.3 Takeda Azilsartan Medoxomil API Sales, Revenue and Gross Margin (2017-2022) 56
11.1.4 Takeda Azilsartan Medoxomil API Products Offered 56
11.1.5 Takeda Recent Development 57
11.2 Lupin 57
11.2.1 Lupin Corporation Information 57
11.2.2 Lupin Business Overview 58
11.2.3 Lupin Azilsartan Medoxomil API Sales, Revenue and Gross Margin (2017-2022) 58
11.2.4 Lupin Azilsartan Medoxomil API Products Offered 58
11.2.5 Lupin Recent Development 59
11.3 Acura Labs 59
11.3.1 Acura Labs Corporation Information 59
11.3.2 Acura Labs Business Overview 60
11.3.3 Acura Labs Azilsartan Medoxomil API Sales, Revenue and Gross Margin (2017-2022) 60
11.3.4 Acura Labs Azilsartan Medoxomil API Products Offered 60
11.3.5 Acura Labs Recent Development 61
11.4 Metrochem API 61
11.4.1 Metrochem API Corporation Information 61
11.4.2 Metrochem API Business Overview 61
11.4.3 Metrochem API Azilsartan Medoxomil API Sales, Revenue and Gross Margin (2017-2022) 62
11.4.4 Metrochem API Azilsartan Medoxomil API Products Offered 62
11.4.5 Metrochem API Recent Development 62
11.5 Jubilant Pharma 63
11.5.1 Jubilant Pharma Corporation Information 63
11.5.2 Jubilant Pharma Business Overview 63
11.5.3 Jubilant Pharma Azilsartan Medoxomil API Sales, Revenue and Gross Margin (2017-2022) 64
11.5.4 Jubilant Pharma Azilsartan Medoxomil API Products Offered 64
11.5.5 Jubilant Pharma Recent Development 64
11.6 Zhejiang Hongyuan 65
11.6.1 Zhejiang Hongyuan Corporation Information 65
11.6.2 Zhejiang Hongyuan Business Overview 65
11.6.3 Zhejiang Hongyuan Azilsartan Medoxomil API Sales, Revenue and Gross Margin (2017-2022) 66
11.6.4 Zhejiang Hongyuan Azilsartan Medoxomil API Products Offered 66
11.6.5 Zhejiang Hongyuan Recent Development 66
11.7 Honour Lab 67
11.7.1 Honour Lab Corporation Information 67
11.7.2 Honour Lab Business Overview 67
11.7.3 Honour Lab Azilsartan Medoxomil API Sales, Revenue and Gross Margin (2017-2022) 68
11.7.4 Honour Lab Azilsartan Medoxomil API Products Offered 68
11.7.5 Honour Lab Recent Development 68
11.8 HEC Pharm 68
11.8.1 HEC Pharm Corporation Information 68
11.8.2 HEC Pharm Business Overview 69
11.8.3 HEC Pharm Azilsartan Medoxomil API Sales, Revenue and Gross Margin (2017-2022) 69
11.8.4 HEC Pharm Azilsartan Medoxomil API Products Offered 70
11.8.5 HEC Pharm Recent Development 70
11.9 Enomark 70
11.9.1 Enomark Corporation Information 70
11.9.2 Enomark Business Overview 71
11.9.3 Enomark Azilsartan Medoxomil API Sales, Revenue and Gross Margin (2017-2022) 71
11.9.4 Enomark Azilsartan Medoxomil API Products Offered 72
11.9.5 Enomark Recent Development 72
11.10 CTX Life Sciences 72
11.10.1 CTX Life Sciences Corporation Information 72
11.10.2 CTX Life Sciences Business Overview 73
11.10.3 CTX Life Sciences Azilsartan Medoxomil API Sales, Revenue and Gross Margin (2017-2022) 73
11.10.4 CTX Life Sciences Azilsartan Medoxomil API Products Offered 74
11.10.5 CTX Life Sciences Recent Development 74
11.11 Zhejiang Tianyu Pharmaceutical 74
11.11.1 Zhejiang Tianyu Pharmaceutical Corporation Information 74
11.11.2 Zhejiang Tianyu Pharmaceutical Business Overview 75
11.11.3 Zhejiang Tianyu Pharmaceutical Azilsartan Medoxomil API Sales, Revenue and Gross Margin (2017-2022) 75
11.11.4 Zhejiang Tianyu Pharmaceutical Azilsartan Medoxomil API Products Offered 75
11.11.5 Zhejiang Tianyu Pharmaceutical Recent Development 76
11.12 Zhuhai Rundu Pharmaceutical 76
11.12.1 Zhuhai Rundu Pharmaceutical Corporation Information 76
11.12.2 Zhuhai Rundu Pharmaceutical Business Overview 77
11.12.3 Zhuhai Rundu Pharmaceutical Azilsartan Medoxomil API Sales, Revenue and Gross Margin (2017-2022) 77
11.12.4 Zhuhai Rundu Pharmaceutical Azilsartan Medoxomil API Products Offered 77
11.12.5 Zhuhai Rundu Pharmaceutical Recent Development 78
11.13 Valiant Co 78
11.13.1 Valiant Co Corporation Information 78
11.13.2 Valiant Co Business Overview 79
11.13.3 Valiant Co Azilsartan Medoxomil API Sales, Revenue and Gross Margin (2017-2022) 79
11.13.4 Valiant Co Azilsartan Medoxomil API Products Offered 79
11.13.5 Valiant Co Recent Development 80
12 Azilsartan Medoxomil API Manufacturing Cost Analysis 81
12.1 Azilsartan Medoxomil API Key Raw Materials Analysis 81
12.1.1 Key Raw Materials 81
12.1.2 Key Suppliers of Raw Materials 81
12.2 Proportion of Manufacturing Cost Structure 82
12.3 Manufacturing Process Analysis of Azilsartan Medoxomil API 82
12.4 Azilsartan Medoxomil API Industrial Chain Analysis 83
13 Marketing Channel, Distributors and Customers 84
13.1 Marketing Channel 84
13.2 Azilsartan Medoxomil API Distributors List 85
13.3 Azilsartan Medoxomil API Customers 86
14 Azilsartan Medoxomil API Market Dynamics 87
14.1 Azilsartan Medoxomil API Industry Trends 87
14.2 Azilsartan Medoxomil API Market Drivers 87
14.3 Azilsartan Medoxomil API Market Challenges 88
14.4 Azilsartan Medoxomil API Market Restraints 88
15 Global Azilsartan Medoxomil Drug Revenue Forecast by Region and Company 89
15.1 North America 89
15.1.1 North America Azilsartan Medoxomil Drug Revenue Forecast (2023-2028) 89
15.2 Europe 89
15.2.1 Europe Azilsartan Medoxomil Drug Revenue Forecast (2023-2028) 89
15.3 APAC 90
15.3.1 APAC Azilsartan Medoxomil Drug Revenue Forecast (2023-2028) 90
15.4 Latin America 90
15.4.1 Latin America Azilsartan Medoxomil Drug Revenue Forecast (2023-2028) 90
15.5 Middle East and Africa 91
15.5.1 Middle East and Africa Azilsartan Medoxomil Drug Revenue Forecast (2023-2028) 91
16 Research Findings and Conclusion 92
17 Appendix 93
17.1 Research Methodology 93
17.1.1 Methodology/Research Approach 93
17.1.2 Data Source 96
17.2 Author Details 99
17.3 Disclaimer 100

 

ページTOPに戻る


 

Summary

Market Analysis and Insights: Global Azilsartan Medoxomil API Market
Due to the COVID-19 pandemic, the global Azilsartan Medoxomil API market size is estimated to be worth 15.05 Million USD in 2021 and is forecast to a readjusted size of 55.68 Million USD by 2028 with a CAGR of 19.96% during the review period (2022-2028).
Global Azilsartan Medoxomil API Scope and Market Size
The global Azilsartan Medoxomil API market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Azilsartan Medoxomil API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country) and by Application for the period 2017-2028.

By Company
Takeda
Lupin
Acura Labs
Metrochem API
Jubilant Pharma
Zhejiang Hongyuan
Honour Lab
HEC Pharm
Enomark
CTX Life Sciences
Zhejiang Tianyu
Zhuhai Rundu
Valiant Co

Segment by Application
20 mg Tablets
40 mg Tablets
80 mg Tablets
By Region
United States
Europe
China
Japan
India
Latin America
Other Regions



ページTOPに戻る


Table of Contents


1 Azilsartan Medoxomil API Market Overview 1
1.1 Azilsartan Medoxomil API Product Scope 1
1.2 Azilsartan Medoxomil API Segment by Application 1
1.2.1 Global Azilsartan Medoxomil API Sales Comparison by Application (2017 & 2021 & 2028) 2
1.2.2 20 mg Tablets 3
1.2.3 40 mg Tablets 4
1.2.4 80 mg Tablets 4
1.3 Global Azilsartan Medoxomil API Market Estimates and Forecasts (2017-2028) 5
1.3.1 Global Azilsartan Medoxomil API Market Size in Value Growth Rate (2017-2028) 5
1.3.2 Global Azilsartan Medoxomil API Market Size in Volume Growth Rate (2017-2028) 7
1.3.3 Global Azilsartan Medoxomil API Price Trends (2017-2028) 8
2 Azilsartan Medoxomil API Estimates and Forecasts by Region 9
2.1 Global Azilsartan Medoxomil API Market Size by Region: 2017 VS 2021 VS 2028 9
2.2 Global Azilsartan Medoxomil API Retrospective Market Scenario by Region (2017-2022) 10
2.2.1 Global Azilsartan Medoxomil API Sales Market Share by Region (2017-2022) 10
2.2.2 Global Azilsartan Medoxomil API Revenue Market Share by Region (2017-2022) 11
2.3 Global Azilsartan Medoxomil API Market Estimates and Forecasts by Region (2023-2028) 13
2.3.1 Global Azilsartan Medoxomil API Sales Estimates and Forecasts by Region (2023-2028) 13
2.3.2 Global Azilsartan Medoxomil API Revenue Forecast by Region (2023-2028) 13
2.4 Geographic Market Analysis: Market Facts & Figures 15
2.4.1 United States Azilsartan Medoxomil API Estimates and Projections (2017-2028) 15
2.4.2 Europe Azilsartan Medoxomil API Estimates and Projections (2017-2028) 16
2.4.3 China Azilsartan Medoxomil API Estimates and Projections (2017-2028) 17
2.4.4 Japan Azilsartan Medoxomil API Estimates and Projections (2017-2028) 18
2.4.5 India Azilsartan Medoxomil API Estimates and Projections (2017-2028) 19
2.4.6 Latin America Azilsartan Medoxomil API Estimates and Projections (2017-2028) 20
3 Azilsartan Medoxomil API Competition Landscape by Players 22
3.1 Global Top Azilsartan Medoxomil API Players by Sales (2017-2022) 22
3.2 Global Top Azilsartan Medoxomil API Players by Revenue (2017-2022) 23
3.3 Global Azilsartan Medoxomil API Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Azilsartan Medoxomil API as of 2021) 25
3.4 Global Azilsartan Medoxomil API Average Price by Company (2017-2022) 27
3.5 Manufacturers Azilsartan Medoxomil API Manufacturing Sites, Area Served 28
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans 29
4 Global Azilsartan Medoxomil API Market Size by Application 30
4.1 Global Azilsartan Medoxomil API Historic Market Review by Application (2017-2022) 30
4.1.1 Global Azilsartan Medoxomil API Sales by Application (2017-2022) 30
4.1.2 Global Azilsartan Medoxomil API Revenue by Application (2017-2022) 30
4.1.3 Global Azilsartan Medoxomil API Price by Application (2017-2022) 32
4.2 Global Azilsartan Medoxomil API Market Estimates and Forecasts by Application (2023-2028) 32
4.2.1 Global Azilsartan Medoxomil API Sales Forecast by Application (2023-2028) 32
4.2.2 Global Azilsartan Medoxomil API Revenue Forecast by Application (2023-2028) 33
4.2.3 Global Azilsartan Medoxomil API Price Forecast by Application (2023-2028) 33
5 United States Azilsartan Medoxomil API Market Facts & Figures 34
5.1 United States Azilsartan Medoxomil API Sales by Company 34
5.1.1 United States Azilsartan Medoxomil API Sales by Company (2017-2022) 34
5.1.2 United States Azilsartan Medoxomil API Revenue by Company (2017-2022) 35
5.2 United States Azilsartan Medoxomil API Sales Breakdown by Application 36
5.2.1 United States Azilsartan Medoxomil API Sales Breakdown by Application (2017-2022) 36
5.2.2 United States Azilsartan Medoxomil API Sales Breakdown by Application (2023-2028) 36
6 Europe Azilsartan Medoxomil API Market Facts & Figures 38
6.1 Europe Azilsartan Medoxomil API Sales by Company 38
6.1.1 Europe Azilsartan Medoxomil API Sales by Company (2017-2022) 38
6.1.2 Europe Azilsartan Medoxomil API Revenue by Company (2017-2022) 38
6.2 Europe Azilsartan Medoxomil API Sales Breakdown by Application 39
6.2.1 Europe Azilsartan Medoxomil API Sales Breakdown by Application (2017-2022) 39
6.2.2 Europe Azilsartan Medoxomil API Sales Breakdown by Application (2023-2028) 40
7 China Azilsartan Medoxomil API Market Facts & Figures 41
7.1 China Azilsartan Medoxomil API Sales by Company 41
7.1.1 China Azilsartan Medoxomil API Sales by Company (2017-2022) 41
7.1.2 China Azilsartan Medoxomil API Revenue by Company (2017-2022) 41
7.2 China Azilsartan Medoxomil API Sales Breakdown by Application 42
7.2.1 China Azilsartan Medoxomil API Sales Breakdown by Application (2017-2022) 42
7.2.2 China Azilsartan Medoxomil API Sales Breakdown by Application (2023-2028) 43
8 Japan Azilsartan Medoxomil API Market Facts & Figures 44
8.1 Japan Azilsartan Medoxomil API Sales by Company 44
8.1.1 Japan Azilsartan Medoxomil API Sales by Company (2017-2022) 44
8.1.2 Japan Azilsartan Medoxomil API Revenue by Company (2017-2022) 44
8.2 Japan Azilsartan Medoxomil API Sales Breakdown by Application 45
8.2.1 Japan Azilsartan Medoxomil API Sales Breakdown by Application (2017-2022) 45
8.2.2 Japan Azilsartan Medoxomil API Sales Breakdown by Application (2023-2028) 46
9 India Azilsartan Medoxomil API Market Facts & Figures 47
9.1 India Azilsartan Medoxomil API Sales by Company 47
9.1.1 India Azilsartan Medoxomil API Sales by Company (2017-2022) 47
9.1.2 India Azilsartan Medoxomil API Revenue by Company (2017-2022) 48
9.2 India Azilsartan Medoxomil API Sales Breakdown by Application 49
9.2.1 India Azilsartan Medoxomil API Sales Breakdown by Application (2017-2022) 49
9.2.2 India Azilsartan Medoxomil API Sales Breakdown by Application (2023-2028) 49
10 Latin America Azilsartan Medoxomil API Market Facts & Figures 51
10.1 Latin America Azilsartan Medoxomil API Sales by Company 51
10.1.1 Latin America Azilsartan Medoxomil API Sales by Company (2017-2022) 51
10.1.2 Latin America Azilsartan Medoxomil API Revenue by Company (2017-2022) 52
10.2 Latin America Azilsartan Medoxomil API Sales Breakdown by Application 53
10.2.1 Latin America Azilsartan Medoxomil API Sales Breakdown by Application (2017-2022) 53
10.2.2 Latin America Azilsartan Medoxomil API Sales Breakdown by Application (2023-2028) 53
11 Company Profiles and Key Figures in Azilsartan Medoxomil API Business 55
11.1 Takeda 55
11.1.1 Takeda Corporation Information 55
11.1.2 Takeda Business Overview 55
11.1.3 Takeda Azilsartan Medoxomil API Sales, Revenue and Gross Margin (2017-2022) 56
11.1.4 Takeda Azilsartan Medoxomil API Products Offered 56
11.1.5 Takeda Recent Development 57
11.2 Lupin 57
11.2.1 Lupin Corporation Information 57
11.2.2 Lupin Business Overview 58
11.2.3 Lupin Azilsartan Medoxomil API Sales, Revenue and Gross Margin (2017-2022) 58
11.2.4 Lupin Azilsartan Medoxomil API Products Offered 58
11.2.5 Lupin Recent Development 59
11.3 Acura Labs 59
11.3.1 Acura Labs Corporation Information 59
11.3.2 Acura Labs Business Overview 60
11.3.3 Acura Labs Azilsartan Medoxomil API Sales, Revenue and Gross Margin (2017-2022) 60
11.3.4 Acura Labs Azilsartan Medoxomil API Products Offered 60
11.3.5 Acura Labs Recent Development 61
11.4 Metrochem API 61
11.4.1 Metrochem API Corporation Information 61
11.4.2 Metrochem API Business Overview 61
11.4.3 Metrochem API Azilsartan Medoxomil API Sales, Revenue and Gross Margin (2017-2022) 62
11.4.4 Metrochem API Azilsartan Medoxomil API Products Offered 62
11.4.5 Metrochem API Recent Development 62
11.5 Jubilant Pharma 63
11.5.1 Jubilant Pharma Corporation Information 63
11.5.2 Jubilant Pharma Business Overview 63
11.5.3 Jubilant Pharma Azilsartan Medoxomil API Sales, Revenue and Gross Margin (2017-2022) 64
11.5.4 Jubilant Pharma Azilsartan Medoxomil API Products Offered 64
11.5.5 Jubilant Pharma Recent Development 64
11.6 Zhejiang Hongyuan 65
11.6.1 Zhejiang Hongyuan Corporation Information 65
11.6.2 Zhejiang Hongyuan Business Overview 65
11.6.3 Zhejiang Hongyuan Azilsartan Medoxomil API Sales, Revenue and Gross Margin (2017-2022) 66
11.6.4 Zhejiang Hongyuan Azilsartan Medoxomil API Products Offered 66
11.6.5 Zhejiang Hongyuan Recent Development 66
11.7 Honour Lab 67
11.7.1 Honour Lab Corporation Information 67
11.7.2 Honour Lab Business Overview 67
11.7.3 Honour Lab Azilsartan Medoxomil API Sales, Revenue and Gross Margin (2017-2022) 68
11.7.4 Honour Lab Azilsartan Medoxomil API Products Offered 68
11.7.5 Honour Lab Recent Development 68
11.8 HEC Pharm 68
11.8.1 HEC Pharm Corporation Information 68
11.8.2 HEC Pharm Business Overview 69
11.8.3 HEC Pharm Azilsartan Medoxomil API Sales, Revenue and Gross Margin (2017-2022) 69
11.8.4 HEC Pharm Azilsartan Medoxomil API Products Offered 70
11.8.5 HEC Pharm Recent Development 70
11.9 Enomark 70
11.9.1 Enomark Corporation Information 70
11.9.2 Enomark Business Overview 71
11.9.3 Enomark Azilsartan Medoxomil API Sales, Revenue and Gross Margin (2017-2022) 71
11.9.4 Enomark Azilsartan Medoxomil API Products Offered 72
11.9.5 Enomark Recent Development 72
11.10 CTX Life Sciences 72
11.10.1 CTX Life Sciences Corporation Information 72
11.10.2 CTX Life Sciences Business Overview 73
11.10.3 CTX Life Sciences Azilsartan Medoxomil API Sales, Revenue and Gross Margin (2017-2022) 73
11.10.4 CTX Life Sciences Azilsartan Medoxomil API Products Offered 74
11.10.5 CTX Life Sciences Recent Development 74
11.11 Zhejiang Tianyu Pharmaceutical 74
11.11.1 Zhejiang Tianyu Pharmaceutical Corporation Information 74
11.11.2 Zhejiang Tianyu Pharmaceutical Business Overview 75
11.11.3 Zhejiang Tianyu Pharmaceutical Azilsartan Medoxomil API Sales, Revenue and Gross Margin (2017-2022) 75
11.11.4 Zhejiang Tianyu Pharmaceutical Azilsartan Medoxomil API Products Offered 75
11.11.5 Zhejiang Tianyu Pharmaceutical Recent Development 76
11.12 Zhuhai Rundu Pharmaceutical 76
11.12.1 Zhuhai Rundu Pharmaceutical Corporation Information 76
11.12.2 Zhuhai Rundu Pharmaceutical Business Overview 77
11.12.3 Zhuhai Rundu Pharmaceutical Azilsartan Medoxomil API Sales, Revenue and Gross Margin (2017-2022) 77
11.12.4 Zhuhai Rundu Pharmaceutical Azilsartan Medoxomil API Products Offered 77
11.12.5 Zhuhai Rundu Pharmaceutical Recent Development 78
11.13 Valiant Co 78
11.13.1 Valiant Co Corporation Information 78
11.13.2 Valiant Co Business Overview 79
11.13.3 Valiant Co Azilsartan Medoxomil API Sales, Revenue and Gross Margin (2017-2022) 79
11.13.4 Valiant Co Azilsartan Medoxomil API Products Offered 79
11.13.5 Valiant Co Recent Development 80
12 Azilsartan Medoxomil API Manufacturing Cost Analysis 81
12.1 Azilsartan Medoxomil API Key Raw Materials Analysis 81
12.1.1 Key Raw Materials 81
12.1.2 Key Suppliers of Raw Materials 81
12.2 Proportion of Manufacturing Cost Structure 82
12.3 Manufacturing Process Analysis of Azilsartan Medoxomil API 82
12.4 Azilsartan Medoxomil API Industrial Chain Analysis 83
13 Marketing Channel, Distributors and Customers 84
13.1 Marketing Channel 84
13.2 Azilsartan Medoxomil API Distributors List 85
13.3 Azilsartan Medoxomil API Customers 86
14 Azilsartan Medoxomil API Market Dynamics 87
14.1 Azilsartan Medoxomil API Industry Trends 87
14.2 Azilsartan Medoxomil API Market Drivers 87
14.3 Azilsartan Medoxomil API Market Challenges 88
14.4 Azilsartan Medoxomil API Market Restraints 88
15 Global Azilsartan Medoxomil Drug Revenue Forecast by Region and Company 89
15.1 North America 89
15.1.1 North America Azilsartan Medoxomil Drug Revenue Forecast (2023-2028) 89
15.2 Europe 89
15.2.1 Europe Azilsartan Medoxomil Drug Revenue Forecast (2023-2028) 89
15.3 APAC 90
15.3.1 APAC Azilsartan Medoxomil Drug Revenue Forecast (2023-2028) 90
15.4 Latin America 90
15.4.1 Latin America Azilsartan Medoxomil Drug Revenue Forecast (2023-2028) 90
15.5 Middle East and Africa 91
15.5.1 Middle East and Africa Azilsartan Medoxomil Drug Revenue Forecast (2023-2028) 91
16 Research Findings and Conclusion 92
17 Appendix 93
17.1 Research Methodology 93
17.1.1 Methodology/Research Approach 93
17.1.2 Data Source 96
17.2 Author Details 99
17.3 Disclaimer 100

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(アプリケーションソフト)の最新刊レポート

本レポートと同じKEY WORD(api)の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/15 10:26

157.84 円

166.62 円

202.61 円

ページTOPに戻る